CCDC42
Coiled-coil domain-containing protein 42
Also known as: CCD42_HUMAN, CCDC42A, FLJ32734
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96M95
- Gene
- CCDC42
- Ensembl
- ENSG00000161973
- Chromosome
- 17
- Canonical length
- 316 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be involved in spermatid development. Predicted to act upstream of or within acrosome assembly; centrosome cycle; and cilium assembly. Predicted to be located in several cellular components, including microtubule cytoskeleton; sperm head-tail coupling apparatus; and sperm principal piece. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
316 residues, UniProt reviewed canonical sequence.
>Q96M95|CCDC42
1 MSLGIMEEED LAEYFRLQYG ERLLQMLQKL PNVEGASESP SIWLLEKKKE TEIMHQTMVQ
61 KKKMFQRRME TLNLRWEELG VKEAQLKAHI QKSEQFIQEN DQKRIRAMKK ANKERELKCQ
121 HMQELTKRKQ EMVALRLEHQ RLSAKLKDYY IFNKYLEKVV ENSEFEEIHE VIARYKTLVS
181 MRHDLMQSAQ EGQEKIERAK ARLARYMEEK DDEILQQNNE LARLQMRFDR ARSNVIFWES
241 RWAHIQNTAA KKTLLLGTIK MATLNLFQIV SKHLKEVTEV ALEDTHKQLD MIQQFIQDRS
301 DIWAEVKKKE QQRVRILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CCDC42 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- testis: 90 nTPM
- blood vessel: 1.4 nTPM
- bone marrow: 0.2 nTPM
- liver: 0.2 nTPM
- lung: 0.2 nTPM
- spleen: 0.2 nTPM
Single-cell type
- late primary spermatocytes: 624 nCPM
- early primary spermatocytes: 54 nCPM
- late spermatids: 47 nCPM
- early spermatids: 33 nCPM
- hematopoietic stem cells: 7.8 nCPM
- megakaryocyte-erythroid progenitors: 2.6 nCPM
Immune cell
- memory B-cell: 0.3 nTPM
- memory CD4 T-cell: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
- memory CD8 T-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- naive CD8 T-cell: 0.1 nTPM
Brain region
- cerebral cortex: 0.7 nTPM
- white matter: 0.5 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CCDC42 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CCDC42 as an antibody target. Whether an autoantibody or antibody against CCDC42 could matter depends on whether native CCDC42 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CCDC42 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CCDC42 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...